En masse nascent transcription analysis to elucidate regulatory transcription factors

Despite exhaustively informing about steady-state mRNA abundance, DNA microarrays have been used with limited success to identify regulatory transcription factors (TFs). The main limitation of this approach is that altered mRNA stability also strongly governs the patterns of expressed genes. Here, we used nuclear run-on assays and microarrays to systematically interrogate changes in nascent transcription in cells treated with the topoisomerase inhibitor camptothecin (CPT). Analysis of the promoters of coordinately transcribed genes after CPT treatment suggested the involvement of TFs c-Myb and Rfx1. The predicted CPT-dependent associations were subsequently confirmed by chromatin immunoprecipitation assays. Importantly, after RNAi-mediated knockdown of each TF, the CPT-elicited induction of c-Myb- and/or Rfx1-regulated mRNAs was diminished and the overall cellular response was impaired. The strategies described here permit the successful identification of the TFs responsible for implementing adaptive gene expression programs in response to cellular stimulation.

[1]  R. Herrmann,et al.  Comparative analysis of plastid transcription profiles of entire plastid chromosomes from tobacco attributed to wild-type and PEP-deficient transcription machineries. , 2002, The Plant journal : for cell and molecular biology.

[2]  P. Emery,et al.  RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. , 1996, Nucleic acids research.

[3]  William C Reinhold,et al.  Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. , 2002, Cancer research.

[4]  Z. Kozmík,et al.  Myb-interacting Protein, ATBF1, Represses Transcriptional Activity of Myb Oncoprotein* , 1999, The Journal of Biological Chemistry.

[5]  M. Husain,et al.  c-Myb-binding Sites Mediate G1/S-associated Repression of the Plasma Membrane Ca2+-ATPase-1 Promoter* , 2000, The Journal of Biological Chemistry.

[6]  E. Reddy,et al.  The myb gene family in cell growth, differentiation and apoptosis , 1999, Oncogene.

[7]  M. Gorospe,et al.  Control of gene expression during T cell activation: alternate regulation of mRNA transcription and mRNA stability , 2005, BMC Genomics.

[8]  T. Gonda The c-Myb oncoprotein. , 1998, The international journal of biochemistry & cell biology.

[9]  Zhiping Weng,et al.  PromoSer: a large-scale mammalian promoter and transcription start site identification service , 2003, Nucleic Acids Res..

[10]  B. Durand,et al.  RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer , 1993, Molecular and cellular biology.

[11]  J. Lipsick,et al.  Myb and oncogenesis. , 1999, Advances in cancer research.

[12]  Ulus Atasoy,et al.  Genome-wide regulatory analysis using en masse nuclear run-ons emRUNs and ribonomic profiling with autoimmune sera , 2003 .

[13]  John S. Satterlee,et al.  Native E2F/RBF Complexes Contain Myb-Interacting Proteins and Repress Transcription of Developmentally Controlled E2F Target Genes , 2004, Cell.

[14]  T. Tahirov,et al.  Eukaryotic transcriptional regulatory complexes: cooperativity from near and afar. , 2003, Current opinion in structural biology.

[15]  Gail Mandel,et al.  Defining the CREB Regulon A Genome-Wide Analysis of Transcription Factor Regulatory Regions , 2004, Cell.

[16]  K. Weston Reassessing the role of C-MYB in tumorigenesis , 1999, Oncogene.

[17]  A. Weinmann,et al.  Novel ChIP-based strategies to uncover transcription factor target genes in the immune system , 2004, Nature Reviews Immunology.

[18]  M. Mathews,et al.  Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter. , 1995, Nucleic acids research.

[19]  M. Introna,et al.  How can oncogenic transcription factors cause cancer: a critical review of the myb story , 1999, Leukemia.

[20]  M. Gorospe,et al.  Global analysis of stress-regulated mRNA turnover by using cDNA arrays , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Sastre,et al.  RNAPol-ChIP: a novel application of chromatin immunoprecipitation to the analysis of real-time gene transcription. , 2004, Nucleic acids research.

[22]  T. Graf Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells , 1992, Current Biology.

[23]  Lin Chen,et al.  Combinatorial gene regulation by eukaryotic transcription factors. , 1999, Current opinion in structural biology.

[24]  K. Becker,et al.  Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.

[25]  I. Sur,et al.  Involvement of RFX proteins in transcriptional activation from a Ras-responsive enhancer element , 2004, Archives of Dermatological Research.

[26]  M. Gorospe,et al.  Global mRNA Stabilization Preferentially Linked to Translational Repression during the Endoplasmic Reticulum Stress Response , 2004, Molecular and Cellular Biology.

[27]  Scott A Tenenbaum,et al.  Genome-wide regulatory analysis using en masse nuclear run-ons and ribonomic profiling with autoimmune sera. , 2003, Gene.

[28]  P. Hearing,et al.  Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region , 1989, Molecular and cellular biology.

[29]  Andrew J. Wilson,et al.  Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. , 2003, Cancer research.

[30]  A. Khodursky,et al.  Life after transcription--revisiting the fate of messenger RNA. , 2003, Trends in genetics : TIG.

[31]  Stephen K. Burley,et al.  Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding , 2000, Nature.

[32]  J. Nevins,et al.  E2Fs link the control of G1/S and G2/M transcription , 2004, The EMBO journal.

[33]  U. Weidle,et al.  The transcriptional program of a human B cell line in response to Myc. , 2001, Nucleic acids research.

[34]  Barbara D. Smith,et al.  The RFX Family Interacts at the Collagen (COL1A2) Start Site and Represses Transcription* , 2002, The Journal of Biological Chemistry.

[35]  P. Farnham,et al.  Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. , 2002, Methods.

[36]  S. Hecht,et al.  Camptothecin: current perspectives. , 2004, Bioorganic & medicinal chemistry.